Efficacy and Tolerability of Anthracycline-Based Therapy in Elderly Patients With Diffuse Large B-Cell Lymphoma

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2014.12.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Anthracycline Dose Intensification in Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Non-Anthracycline Chemotherapy Associated With a Poor Outcome in Elderly Egyptian Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma

Journal of Cancer Metastasis and Treatment
2015English

Impact of Comorbidities on Outcomes of Elderly Patients With Diffuse Large B-Cell Lymphoma

American Journal of Hematology
Hematology
2017English

Diffuse Large B-Cell Lymphoma

2020English

Antiviral Therapy and Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) With Hepatitis C (Hcv)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Clinical Significance of T-Cell Exhaustion in Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Clinical and Hematological Predictors of Response to First-Line Therapy in Patients With Diffuse Large B-Cell Lymphoma

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2018English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy